40 years of the HIV/AIDS response
The Lancet Voice
00:00
What's Next for the Field?
The messenger anays 94 and 95 % efficacy, an extraordinary safety. And yout knhais been such a long, slow process and a very frustrating one. We still do see the as related malignancies as as a big problem, and it isn't clear that effective therapy can be found for them.
Transcript
Play full episode
